Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-10-12
1998-08-04
Owens, Amelia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142278, 5142322, 514255, 514314, 514336, 514374, 514378, 514397, 514414, 514422, 514432, 514444, 514451, 514459, 549 28, 549 60, 549292, 549293, 549294, 549426, 549427, 546135, 5462821, 544 60, 544149, 544374, 548247, 548235, 5483111, 548465, 548509, 548517, A61K 3135, A61K 3138, A61K 3140, A61K 3142, A61K 31495, A61K 3154
Patent
active
057894400
ABSTRACT:
The present invention relates to novel 5,6-dihydropyrone derivatives and related structures which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The 5,6-dihydropyrone derivatives are useful in the development of therapies for the treatment of bacterial and viral infections and diseases, including AIDS. The present invention is also directed to methods of synthesis of multifunctionalized 5,6-dihydropyrones and of related structures.
REFERENCES:
patent: 3206476 (1965-09-01), Collins
patent: 3818046 (1974-06-01), Harris et al.
patent: 3931235 (1976-06-01), Harris et al.
D. Richman, "Control of Virus Diseases," 45th Symposium of the Society for General Microbiology, 1990, 261-313.
H. Toh, et al., Nature, 1985, 315:691.
J. Kay, et al., Biochim. Biophys. Acta 1: 1990, 1048.
C. Cameron, et al., J. Biological Chem. 168, 1993, 11711-720.
M. Graves, Structure and Function of the Aspartic Protease 1991, 395-405.
C. Peng, et al., J. Virol.,63: 1989, 2550-2556.
N. Kohl, et al., Proc. Nat. Acad. Sci. USA,85:1988,4689-90.
J.C. Craig, et al, Antiviral Research, 16:1991, 295-305.
A.G. Tomasselli, et al., Chimica Oggi, 9:1991,6-27.
T. Meek, J. Enzyme Inhibition, 6: 1992, 65-98.
R. Nagorny, et al, AIDS, 7:1993, 129-130.
D.P. Fairlie, et al., Biochem. Biophys. Res. Comm., 188: 1992, 631-637.
S. Thaisrivongs, et al., J. Med. Chem., 1994, 37, 3200-3204.
M. Ruwart, et al., American Association of Pharmaceutical Scientists Meeting--Abstract/PDD 7290, Nov. 6-10, 1994.
Ellsworth Edmund Lee
Lunney Elizabeth
Tait Bradley Dean
Anderson Elizabeth M.
Owens Amelia
Warner-Lambert & Company
LandOfFree
5,6-dihydropyrone derivatives as protease inhibitors and antivir does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5,6-dihydropyrone derivatives as protease inhibitors and antivir, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5,6-dihydropyrone derivatives as protease inhibitors and antivir will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1177666